| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |